C12N 2502/253
Bladder cells
C12N2502/253 (Bladder cells) appears on 21 US grants and 19 published applications in this corpus.
Search patents in C12N- Granted patents
- 21
- Published applications
- 19
- Assignees
- 15
- Inventors
- 54
- Latest grant
- 12 Mar 2024
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 1 | 0 |
| 1997 | 1 | 0 |
| 1998 | 1 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 1 |
| 2004 | 0 | 2 |
| 2005 | 0 | 3 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 2 | 1 |
| 2009 | 0 | 0 |
| 2010 | 1 | 0 |
| 2011 | 2 | 2 |
| 2012 | 1 | 0 |
| 2013 | 1 | 0 |
| 2014 | 1 | 2 |
| 2015 | 1 | 0 |
| 2016 | 0 | 0 |
| 2017 | 0 | 0 |
| 2018 | 0 | 0 |
| 2019 | 1 | 1 |
| 2020 | 0 | 0 |
| 2021 | 0 | 3 |
| 2022 | 0 | 1 |
| 2023 | 0 | 1 |
| 2024 | 3 | 0 |
By publication year. Applications have been published since 2001.
Recent patents
- Perfusable-type dual proximal tubule cell construct and producing method thereof for applying in vitro artificialrenal tissue model and renal cell therapy12 Mar 2024US 11,925,726 B2Postech Research and Business Development Foundation
- Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers13 Feb 2024US 11,897,935 B2Immatics Biotechnologies GmbH
- Peptides, combination of peptides as targets and for use in immunotherapy13 Feb 2024US 11,897,936 B2Immatics Biotechnologies GmbH
- Peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers12 Nov 2019US 10,472,407 B2Immatics Biotechnologies GmbH
- Enhancement of angiogenesis to grafts using cells engineered to produce growth factors27 Jan 2015US 8,940,292 B2Wake Forest University Health Sciences
- Method for manufacturing induced pluripotent stem cells23 Feb 2023US 2023/0055044 A1I Peace, Inc.
- Perfusable-type dual proximal tubule cell construct and producing method thereof for applying in vitro artificialrenal tissue model and renal cell therapy10 Mar 2022US 2022/0072203 A1Postech Research and Business Development Foundation
- Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers30 Dec 2021US 2021/0403531 A1Immatics Biotechnologies GmbH
- Novel peptides, combination of peptides as targets and for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers9 Dec 2021US 2021/0380662 A1Immatics Biotechnologies GmbH
- Assembloid - 3d mimetic tissue structure based on patient- derived multiple cell types and method of manufacturing the same18 Mar 2021US 2021/0079358 A1Postech Research and Business Development Foundation
Most cited
By later US patents
- Preparing artificial organs by forming polylayers of different cell populations on a substrate141US 6,428,802 B1Children's Medical Center Corporation · 2002
- Enhanced growth medium and method for culturing human mammary epithelial cells46US 4,423,145 A1983
- Vascularization enhanced graft constructs40US 7,776,596 B2Purdue Research Foundation · 2010
- Promotion of epithelial cell adhesion and hemidesmosome assembly by a laminin-like molecule33US 5,658,789 ADesmos, Inc. · 1997
- Scaffolds for organ reconstruction and augmentation24US 7,918,897 B2Tengion, Inc. · 2011